TipRanks
Tvardi Therapeutics (DE:69C)
FRANKFURT:69C

Compare Tvardi Therapeutics (69C) vs. Competitors

1 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Tvardi Therapeutics
€1.39
€12.85M
-0.39
-97.35%
4 Buy
1 Hold
1 Sell
Moderate Buy
Cue Biopharma
$28.85
$168.10M
-0.83
-0.27%
1 Buy
0 Hold
0 Sell
Moderate Buy
Aligos Therapeutics
$7.47
$33.60M
-0.73
-45.93%
4 Buy
0 Hold
0 Sell
Strong Buy
Genenta Science SpA Sponsored ADR
$1.02
$37.64M
-2.04
-76.11%
―
Adlai Nortye Ltd. Sponsored ADR
$13.74
$931.19M
-7.19
712.14%
6 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:69C
Tvardi Therapeutics
0.90
-32.75
-97.34%
PSTV
―
―
―
―
CUE
Cue Biopharma
22.51
-3.23
-12.55%
ALGS
Aligos Therapeutics
5.32
-4.61
-46.42%
GNTA
Genenta Science SpA Sponsored ADR
0.76
-2.53
-76.98%
ANL
Adlai Nortye Ltd. Sponsored ADR
14.05
12.32
712.14%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts